DailyBubble News
DailyBubble News

Shenzhen New Industries Biomedical Engineering Co., Ltd. (SZSE:300832) Passed Our Checks, And It’s About To Pay A CN¥1.00 Dividend

At Simply Wall St, we have a strong affinity for dividends, so it’s always exciting when a company like Shenzhen New Industries Biomedical Engineering Co., Ltd. (SZSE:300832) is about to trade ex-dividend in the next 2 days. The ex-dividend date is crucial because it determines which shareholders are eligible for a dividend payment based on their presence on the company’s books. To receive Shenzhen New Industries Biomedical Engineering’s upcoming dividend of CN¥1.00 per share, investors must purchase the stock before the 15th of May, with the payment scheduled for the same day.

Last year, the company distributed a total of CN¥1.00 per share, resulting in a trailing yield of 1.3% based on the current share price of CN¥77.83. Dividends play a significant role in long-term investment returns, but it’s essential to ensure that dividend payments are sustainable and supported by earnings growth. Shenzhen New Industries Biomedical Engineering has been prudent in its dividend payouts, with only 46% of its earnings and 48% of its free cash flow allocated towards dividends in the past year.

The company’s consistent coverage of dividends by both profit and cash flow indicates sustainability, provided that earnings remain stable. Shenzhen New Industries Biomedical Engineering has shown promising growth in earnings per share, increasing at a rate of 17% annually over the past five years. However, the decline in dividend payments per share by 11% per year on average over the last four years raises some concerns, especially when earnings per share are on the rise.

Despite the fluctuation in dividend payments, Shenzhen New Industries Biomedical Engineering presents an attractive dividend opportunity, supported by its growing earnings per share and conservative dividend approach. While there are risks associated with any investment, including this stock, it’s important to conduct thorough research before making a decision. Our analysis can provide valuable insights into the company’s valuation, risks, dividends, insider transactions, and financial health, helping investors make informed choices.

0 0 votes
Article Rating
Notify of
Inline Feedbacks
View all comments
Would love your thoughts, please comment.x